SCHEMBL742316

SCHEMBL742316

COc1ccccc1C(C)(C)NC(=O)c1cc2c(NC(=O)c3ccc(CN4CCC4)cc3)n[nH]c2s1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.57
BCR P11274 2/20 0.57
KDR P35968 1/20 0.47
LMNA P02545 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
HSD17B10 Q99714 3/20 0.42
HPGD P15428 2/20 0.42
MAPT P10636 2/20 0.42
USP2 O75604 1/20 0.42
ALDH1A1 P00352 1/20 0.42
AURKA O14965 1/20 0.42
CYP2C9 P11712 1/20 0.41
TP53 P04637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
TSHR P16473 1/20 0.40
KIT P10721 1/20 0.39
FLT3 P36888 1/20 0.39
HRH3 Q9Y5N1 2/20 0.39
ACKR3 P25106 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL740797 0.98 ABL1 (0.59) ABL1BCRKDRLMNASMN1; SMN2
SCHEMBL740545 0.98 ABL1 (0.60) ABL1BCRKDRLMNASMN1; SMN2
SCHEMBL740827 0.93 ABL1 (0.51) ABL1BCRKDRLMNASMN1; SMN2
SCHEMBL742867 0.89 ABL1 (0.58) ABL1BCRKDRMAPTALDH1A1
SCHEMBL740623 0.88 ABL1 (0.72) ABL1BCRKDRMAPTALDH1A1
SCHEMBL743418 0.88 ABL1 (0.60) ABL1BCRKDRLMNASMN1; SMN2
SCHEMBL2431018 0.88 ABL1 (0.62) ABL1BCRKDRSMN1; SMN2MAPT
SCHEMBL742153 0.88 ABL1 (0.60) ABL1BCRKDRMAPTALDH1A1
SCHEMBL739473 0.87 ABL1 (0.61) ABL1BCRKDRMAPTALDH1A1
SCHEMBL741946 0.87 ABL1 (0.61) ABL1BCRKDRMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed